High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: A challenge to management

Clinical Endocrinology

Volumn 74, Issue 4, 2011, Pages 438-444

  Vassiliadi, Dimitra A ^a   Ntali, Georgia ^a   Vicha, Eirini ^a   Tsagarakis, Stylianos ^a  

^a Athens Polyclinic Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN DERIVATIVE; DEXAMETHASONE; GLUCOSE; HYDROCORTISONE; INSULIN; PRASTERONE SULFATE;

ADRENAL INCIDENTALOMA; ADRENAL SUPPRESSION; ADRENALECTOMY; ADULT; AGE; AGED; ARTICLE; BILATERAL INCIDENTALOMA; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNILATERAL INCIDENTALOMA; URINALYSIS; WAIST HIP RATIO;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; CUSHING SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79952365521     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03963.x     Document Type: Article

References (35)

1. Kloos, R.T., Gross, M.D., Francis, I.R., et al. (1995) Incidentally discovered adrenal masses. Endocrine Reviews, 16, 460-484.
2. Tsagarakis, S., Vassiliadi, D., &, Thalassinos, N., (2006) Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. Journal of Endocrinological Investigation, 29, 471-482. (Pubitemid 44043366)
3. Rossi, R., Tauchmanova, L., Luciano, A., et al. (2000) Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. Journal of Clinical Endocrinology and Metabolism, 85, 1440-1448. (Pubitemid 32289484)
4. Chiodini, I., Morelli, V., Salcuni, A.S., et al. (2010) Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. Journal of Clinical Endocrinology and Metabolism, 95, 2736-2745.
5. Toniato, A., Merante-Boschin, I., Opocher, G., et al. (2009) Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Annals of Surgery, 249, 388-391.
6. Bernini, G., Moretti, A., Iacconi, P., et al. (2003) Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. European Journal of Endocrinology, 148, 213-219. (Pubitemid 36305687)
7. Stewart, P.M., (2010) Is subclinical Cushing's syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined. Journal of Clinical Endocrinology and Metabolism, 95, 2618-2620.
8. Osella, G., Terzolo, M., Borretta, G., et al. (1994) Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). Journal of Clinical Endocrinology and Metabolism, 79, 1532-1539.
9. Barzon, L., Scaroni, C., Sonino, N., et al. (1998) Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. Journal of Clinical Endocrinology and Metabolism, 83, 55-62. (Pubitemid 28498310)
10. Majnik, J., Patocs, A., Balogh, K., et al. (2006) Overrepresentation of the N363S variant of the glucocorticoid receptor gene in patients with bilateral adrenal incidentalomas. Journal of Clinical Endocrinology and Metabolism, 91, 2796-2799. (Pubitemid 44024654)
11. Koch, C.A., Pacak, K., &, Chrousos, G.P., (2002) The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. Journal of Clinical Endocrinology and Metabolism, 87, 5367-5384. (Pubitemid 36034330)
12. Patocs, A., Toth, M., Barta, C., et al. (2002) Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas. European Journal of Endocrinology, 147, 349-355.
13. Nieman, L.K., Biller, B.M., Findling, J.W., et al. (2008) The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 93, 1526-1540. (Pubitemid 351656485)
14. Tsagarakis, S., Roboti, C., Kokkoris, P., et al. (1998) Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clinical Endocrinology, 49, 165-171. (Pubitemid 28372643)
15. Tsagarakis, S., Kokkoris, P., Roboti, C., et al. (1998) The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome. Clinical Endocrinology, 48, 627-633. (Pubitemid 28253000)
16. Terzolo, M., Bovio, S., Pia, A., et al. (2005) Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. European Journal of Endocrinology, 153, 307-315. (Pubitemid 41167489)
17. Papanicolaou, D.A., Yanovski, J.A., Cutler Jr, G.B., et al. (1998) A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. Journal of Clinical Endocrinology and Metabolism, 83, 1163-1167. (Pubitemid 28496386)
18. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419. (Pubitemid 15018832)
19. Matsuda, M., &, DeFronzo, R.A., (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care, 22, 1462-1470. (Pubitemid 29418240)
20. Yener, S., Genc, S., Akinci, B., et al. (2009) Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma. Endocrine, 35, 365-370.
21. Tauchmanova, L., Rossi, R., Biondi, B., et al. (2002) Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. Journal of Clinical Endocrinology and Metabolism, 87, 4872-4878. (Pubitemid 35316318)
22. Mantero, F., Terzolo, M., Arnaldi, G., et al. (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. Journal of Clinical Endocrinology and Metabolism, 85, 637-644.
23. Cawood, T.J., Hunt, P.J., O'Shea, D., et al. (2009) Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? European Journal of Endocrinology, 161, 513-527.
24. Libe, R., Coste, J., Guignat, L., et al. (2010) Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome. European Journal of Endocrinology, 163, 129-138.
25. Lacroix, A., Bourdeau, I., Lampron, A., et al. (2010) Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction. Clinical Endocrinology, 73, 1-15.
26. Bourdeau, I., D'Amour, P., Hamet, P., et al. (2001) Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 86, 5534-5540. (Pubitemid 33070285)
27. Lazurova, I., Dudasova, D., Wagnerova, H., et al. (2006) Adrenal incidentalomas and the metabolic syndrome-are there any differences between adenoma and hyperplasia? Neoplasma, 53, 324-327. (Pubitemid 44105938)
28. Wagnerova, H., Dudasova, D., &, Lazurova, I., (2009) Hormonal and metabolic evaluation of adrenal incidentalomas. Neoplasma, 56, 521-525.
29. Erbil, Y., Ozbey, N., Barbaros, U., et al. (2009) Cardiovascular risk in patients with nonfunctional adrenal incidentaloma: myth or reality? World Journal of Surgery, 33, 2099-2105.
30. Terzolo, M., Pia, A., Ali, A., et al. (2002) Adrenal incidentaloma: a new cause of the metabolic syndrome? Journal of Clinical Endocrinology and Metabolism, 87, 998-1003. (Pubitemid 36121054)
31. Midorikawa, S., Sanada, H., Hashimoto, S., et al. (2001) The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clinical Endocrinology, 54, 797-804. (Pubitemid 34208891)
32. Reincke, M., Fassnacht, M., Vath, S., et al. (1996) Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocrine Research, 22, 757-761. (Pubitemid 26424404)
33. Emral, R., Uysal, A.R., Asik, M., et al. (2003) Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes. Endocrine Journal, 50, 399-408. (Pubitemid 37129032)
34. Tjan-Heijnen, V.C., Hermus, A.R., Kemink, S.A., et al. (1998) Preclinical Cushing's syndrome in patients with an adrenal incidentaloma. Netherlands Journal of Medicine, 52, 111-115. (Pubitemid 28189589)
35. Young Jr, W.F., du Plessis, H., Thompson, G.B., et al. (2008) The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses. World Journal of Surgery, 32, 856-862.